Changes in Bone Density during Long-Term Administration of Low-Molecular-Weight Heparins or Acenocoumarol for Secondary Prophylaxis of Venous Thromboembolism

Publisher： Karger

E-ISSN： 1424-8840|33|2|64-67

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.33, Iss.2, 2003-11, pp. : 64-67

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low-Molecular-Weight Heparins, Acenocoumarol and Bone Density

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 31, Iss. 1, 2001-06 ,pp. : 69-70

Karger

Access to resources Recommend Favorite

Home Treatment of Venous Thromboembolism with Low-Molecular-Weight Heparins

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. : 83-84

Karger

Access to resources Recommend Favorite

Secondary Prevention of Venous Thromboembolism: A Role for Low-Molecular-Weight Heparin

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 5, 1999-07 ,pp. : 236-243

Karger

Access to resources Recommend Favorite

Low molecular weight heparins: the optimal treatment for venous thromboembolism

By Daskalopoulos Marios E.   Daskalopoulou Stella S.   Liapis Christos D.  

Current Medical Research and Opinion, Vol. 20, Iss. 7, 2004-07 ,pp. : 1001-1005

Informa Healthcare

Access to resources Recommend Favorite

Low-Molecular-Weight Heparins: Are They Interchangeable?

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 30, Iss. 2, 2004-11 ,pp. : 148-157

Karger

Access to resources Recommend Favorite